Drug intelligence / Profile preview

Zengru

Development stage: Preclinical

Overview

Zengru is a Chinese herbal medicine, specifically referred to as Zengru Gao, that has been investigated for its ability to promote breastfeeding. Clinical trials have shown that it can enhance breastfeeding success during the first week postpartum. The specific mechanism of action is not detailed in the available information, but it is categorized as a traditional Chinese medicine. It is considered acceptable to participants and warrants further evaluation.

Other names: Zengru Gao

Beyond the preview

Go deeper on Zengru.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zengru.

Explore the full profile